# Olivier Hermine

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/olivier-hermine/

## Facts

| Field | Value |
| --- | --- |
| Citations | 66,105 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 136 |
| i10-index | 789 |
| Last Known Institution | Délégation Paris 5 |
| OpenAlex ID | https://openalex.org/A5064856085 |
| ORCID iD | https://orcid.org/0000-0003-2574-3874 |
| Works | 1,819 |

## Researcher papers

- [Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study](https://scholariq.org/papers/lymphoproliferative-disorders-in-patients-receiving-thiopurines-for-inflammatory/)
- [Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia](https://scholariq.org/papers/effect-of-tocilizumab-vs-usual-care-in-adults-hospitalized-with-covid-19-and/)
- [High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis](https://scholariq.org/papers/high-dose-melphalan-versus-melphalan-plus-dexamethasone-for-al-amyloidosis/)
- [Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II](https://scholariq.org/papers/presentation-and-long-term-follow-up-of-refractory-celiac-disease-comparison-of/)
- [Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies](https://scholariq.org/papers/autoimmune-and-inflammatory-manifestations-occur-frequently-in-patients-with/)
- [Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1](https://scholariq.org/papers/preexisting-autoantibodies-to-type-i-ifns-underlie-critical-covid-19-pneumonia/)
- [Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial](https://scholariq.org/papers/effect-of-anakinra-versus-usual-care-in-adults-in-hospital-with-covid-19-and/)
- [Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial](https://scholariq.org/papers/masitinib-as-an-add-on-therapy-to-riluzole-in-patients-with-amyotrophic-lateral/)
- [Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia](https://scholariq.org/papers/targeting-iron-homeostasis-induces-cellular-differentiation-and-synergizes-with/)
- [Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study](https://scholariq.org/papers/enteropathy-associated-t-cell-lymphoma-in-celiac-disease-a-large-retrospective/)
- [International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study](https://scholariq.org/papers/international-prognostic-scoring-system-for-mastocytosis-ipsm-a-retrospective/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)
- [T-cell and Retrovirus Studies](https://scholariq.org/topics/t-cell-and-retrovirus-studies/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)

## Researcher university

- [Délégation Paris 5](https://scholariq.org/institutions/delegation-paris-5/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.